...89101112...203040...


Foundational step towards a quantum internet – News – The University of Sydney

Dr John Bartholomew in the Quantum Integration Laboratory at the University of Sydney Nano Institute. Photo: Stefanie Zingsheim

Quantum computers promise to revolutionise information technology this century. Based on the rules of quantum mechanics, the very nature of their hardware means they will be able to solve problems beyond the reach of classical computers. And scientists are also working on how best to build a network of these machines in order to create a quantum internet of sorts.

Engineers at Caltech, the California Institute of Technology, have discovered that by embedding atoms of the rare-earth element ytterbium in an optical cavity they are able to control and measure a stable form of quantum information in a solid. The system they have developed has the potential to share that information over thousands of kilometres using photons.

"This ticks most of the boxes, said Caltechs Professor Andrei Faraon, who led the research team. It's a rare-earth ion that absorbs and emits photons in exactly the way we'd need to create a quantum network.

This could form the backbone technology for the quantum internet."

Dr John Bartholomew is a co-author of the Nature paper and worked on the project at Caltech. This year he joined the University of Sydney Nano Institute and School of Physics.

He said: These rare-earth atoms have great appeal for quantum technologies but several challenges had to be overcome to get things working at the single atom level. Ive worked on overcoming these challenges since starting my PhD at the Australian National University 12 years ago.

I saw the nanophotonic cavities pioneered at Caltech as the best shot for making this breakthrough.

Dr Bartholomew now leads the Quantum Integration Laboratory at the University of Sydney. Here he hopes to build on the Universitys demonstrated strengths in photonics and quantum technologies.

The next big steps are to increase the performance and scale of this hardware and I can't wait to tackle these challenges at the University of Sydney by designing new materials and building integrated devices, he said.

As they can with classical computers, engineers would like to be able to connect multiple quantum computers to share data and work together creating a quantum internet. This would open the door to several applications, including solving computations that are too large to be handled by a single machine and establishing provably secure communications using quantum cryptography.

In order to work, a quantum network needs to be able to transmit information between two points without altering the quantum properties of the information being transmitted. The idea is to use one of the fundamental quantum properties of matter, which is entanglement. This is where the information of quantum objects remains dependent on each other, even if separated by an arbitrary distance.

One current model works like this: a single atom or ion acts as a quantum bit (or qubit) storing information via one if its properties, such as the direction of its angular momentum, known as spin. To read that information and transmit it elsewhere, the atom is excited with a pulse of light, causing it to emit a photon whose spin is entangled with the spin of the atom. The photon can then transmit the information entangled with the atom over a long distance via fibre-optic cable.

Doing that is harder than it sounds, however. Finding atoms that you can control and measure that also aren't too sensitive to magnetic or electric field fluctuations that cause errors, or decoherence, is challenging.

"Solid-state emitters that interact well with light often fall victim to decoherence; that is, they stop storing information in a way that's useful from the prospective of quantum engineering," said Caltechs Dr Jon Kindem, lead author of theNaturepaper.

Meanwhile, atoms of rare-earth elements, which have properties that make the elements useful as qubits, tend to interact poorly with light.

To overcome this challenge, researchers led by Professor Faraon constructed a nanophotonic cavity about 10 microns (0.01 millimetres) in length, sculpted from a piece of crystal.

The crystal was made in such a way that light inside it would bounce around in predictable patterns.

They then identified a charged atom, or ion, of the rare-earth element ytterbium was then placed at the centre of the cavity where it could receive a beam of photons. The optical cavity allows for light to bounce back and forth down the beam multiple times until it is finally absorbed by the ion.

In theNaturepaper, the team showed that the cavity modifies the environment of the ion such that whenever it emits a photon, more than 99 percent of the time that photon remains in the cavity, where scientists can efficiently collect and detect that photon to measure the state of the ion. This results in an increase in the rate at which the ion can emit photons, improving the overall effectiveness of the system.

In addition, the ytterbium atoms store information for 30 milliseconds. That doesnt sound long, but its long enough for light to transport that information nearly 6000 kilometres about the distance from Sydney to Jakarta and enough time to cross continental Europe, Asia, Australia or the US.

The team's current focus is on creating the building blocks of a quantum network. Next, they hope to scale up their experiments and connect two quantum bits, Professor Faraon said.

This research was funded by the US National Science Foundation, the US Air Force Office of Scientific Research and theInstitute for Quantum Information and Matterat Caltech and used theKavli Nanoscience Institute Laboratoryat Caltech.

Excerpt from:

Foundational step towards a quantum internet - News - The University of Sydney

IIT and Stanford alumni develop machine to sterilise public places to prevent the spread of coronavirus – YourStory

The novel coronavirus has infected over 7 lakh people worldwide, and has claimed nearly 38,000 lives, according to the World Health Organisation (WHO).

While humanity is racing against time to find a cure for the disease, Delhi-basedPerSapien Innovation has come up with amachine called Airlens Minus Corona (-Corona) to counter the spread of the disease.

Started by Stanford University researchers Debayan Saha and Shashi Ranjan in 2017, PerSapien strongly believes that good health is the birthright of each (Per) human being (Sapien).

Shashi says, the machine is like a Robo Sapien (a human-like machine) that operates on the mechanism of charged/ionised water droplets, which is ionised using the corona discharge. The machine disperses the ionised water droplets, which in turn oxidises the viral protein, and hence reducing it to a non-harmful molecule.

Airlens minus Corona

Debayan adds thatalcohols (like ethanol or IPA) are known to inactivate viruses by denaturing their protein coat. But alcohol-based hand sanitisers are useful on a smaller scale. For example, it is useful for individuals to sanitise their hands, and is also helpful to sanitise surfaces at home, offices, etc.

However, this is insufficient in such an emergency as it is impractical to use alcohol for sanitising cities. Thus, to combat the virus at a larger scale, the entire city needs to be sanitised, for which Airlens Minus Corona (-Corona) has been created, he adds.

The machine can travel on the streets and spray the ionised water droplets, targetting crowded places like hospitals, bus stops, railway stations, markets, etc., to sterilise the city from the spread of the virus.

According to the founders, the startup, which is funded by Gas Authority India Limited (GAIL) and Yes Bank Foundation, is not looking to derive business gains from their invention.

Rather, the co-founders assert that the device is not for commercial sale, and they are planning to open the technology on their website so that anyone can make the device by themselves.

Considering the deadly situation India is exposed to, in order to curb the menace created by the virus, the government authorities will need such technology. Therefore, while the entire country has come together to fight the virus, we would like to contribute by giving Airlens Minus Corona technology to the government to check the spread of the virus, he says.

The founders say they have already tested the device, and the test turned out to be positive. After seeing successful results, they have been in touch with the government to implement the device in order to sterilise public places.

Debayan Saha worked in a drone development sector after completing his bachelors in technology from IIT Kharagpur. He says, an interesting turn of events led him to pursue Global Biodesign Fellowship at Stanford University, California, where he invented couple of medical devices for the US healthcare system.

To create an impact in the healthcare sector back home, he returned to India and joined AIIMS in New Delhi, where he started working on air pollution as a SIB Fellow, mentored by Padmashree Prof. Randeep Guleria, Director of AIIMS, and co-invented a technology.

Shashi Ranjan started his technical career with an engineering degree in Biotechnology from BIT Mesra. He pursued PhD in Biomedical Engineering from National University of Singapore, and authored various research publications in reputed peer reviewed journals like Nature Communications, and got his techniques patented.

Co-Founders of PerSepian Innovations (LtoR) Debayan Saha, and Shashi Ranjan

Shashi says, he is extremely eager to utilise his research to help people. He met Debayan at Stanfords Biodesign fellowship. During his stay at the Stanford University, he developed an innovative and frugal medical device to solve the problem of pace-maker lead dislodgement.

After returning to India, he identified air pollution as one of the biggest problems affecting lives of all. To solve this problem, he developed a novel air purification technology with support from Pfizer IIT Delhi Innovation & IP programme.

(Edited by Megha Reddy)

How has the coronavirus outbreak disrupted your life? And how are you dealing with it? Write to us or send us a video with subject line 'Coronavirus Disruption' to editorial@yourstory.com

Here is the original post:

IIT and Stanford alumni develop machine to sterilise public places to prevent the spread of coronavirus - YourStory

Global Nanotechnology Drug Delivery Market: Industry Analysis and Forecast (2019-2026): By Technology, Application and Region – Publicist360

Global Nanotechnology Drug Delivery Market was valued US$ XX Bn in 2018 and is expected to reach US$ 98.2 Bn by 2026, at a XX% CAGR of around during a forecast period.

Various novel technologies for developing effective drug delivery systems came into existence among which nanotechnology platforms for achieving targeted drug delivery are gaining prominence nowadays. Research in the medical field includes the development of drug nanoparticles, polymeric and inorganic biodegradable nano-carriers for drug delivery, and surface engineering of carrier molecules.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/39035

The report contains a detailed list of factors that will drive and restrain the growth of the Nanotechnology Drug Delivery Market. Such as, rapidly expanding areas of research and development to develop novel nano-medicine are expected to drive the nanotechnology drug delivery market growth in the future. Additionally, one of the major factors assisting market growth is the growing prevalence of infectious diseases and cancer, developing nanotechnology research, and increasing demand for novel drug delivery systems. However, high cost coupled with stringent regulatory scenario hinders the market growth to some extent.

Nanoparticles are expected to account for the largest XX% market share by 2026. The segment dominated the market as key nanoparticles like gold nanoparticles, dendrimers, and fullerenes are used in pharmaceutical drug delivery.The report offers a brief analysis of the major regions in the global nanotechnology drug delivery market, namely, APAC, Europe, North America, South America, and the Middle East & Africa. North America dominated the nanotechnology drug delivery market in 2018, because of high medical reimbursement facilities, and technological advancement. The APAC is projected to have the fastest growth, owing to a rapidly increasing population, an increase in consumer awareness, favorable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing economies such as China, and India in this region.

Nanotechnology drug delivery market report gives a competitive analysis of the individual standing of the companies against the global landscape of the medical industry. The forecast also provides the estimated trends in demand for the global market and their impact on the sizes of these companies to help the reader curate profitable business strategies. Such as Pfizer, Inc., AstraZeneca and Amgen signed agreements to collaborate with BIND Therapeutics to develop nano-medicines. These initiatives are expected to fuel the growth of the nanotechnology drug delivery market in the upcoming future.

The objective of the report is to present comprehensive analysis of Global Nanotechnology Drug Delivery Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Nanotechnology Drug Delivery Market dynamics, structure by analyzing the market segments, and project the Global Nanotechnology Drug Delivery Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nanotechnology Drug Delivery Market make the report investors guide.

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/39035

Scope of the Global Nanotechnology Drug Delivery Market

Global Nanotechnology Drug Delivery Market, by Technology

Nanocrystals Nanoparticleso Dendrimerso Gold Nanoparticleso Dendrimerso Fullereneso Others Liposomes Micelles Nanotubes OthersGlobal Nanotechnology Drug Delivery Market, by Application

Neurology Oncology Cardiovascular/Physiology Anti-inflammatory/Immunology Anti-infective OthersGlobal Nanotechnology Drug Delivery Market, by Region

North America Asia Pacific Europe Middle East & Africa South AmericaKey players operating in the Global Nanotechnology Drug Delivery Market

Johnson & Johnson Merck & Co Roche Bayer Novartis Pharmaceuticals Pfizer AstraZeneca Amgen Celgene Corporation Angiotech Pharmaceuticals Capsulution Pharma AlphaRx Inc. Calando Pharmaceuticals Copernicus Therapeutics Elan Corporation Nanotherapeutics PAR Pharmaceutica Taiwan Liposome Co. AbbVie, Inc Amgen, Inc

MAJOR TOC OF THE REPORT

Chapter One: Nanotechnology Drug Delivery Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Nanotechnology Drug Delivery Market Competition, by Players

Chapter Four: Global Nanotechnology Drug Delivery Market Size by Regions

Chapter Five: North America Nanotechnology Drug Delivery Revenue by Countries

Chapter Six: Europe Nanotechnology Drug Delivery Revenue by Countries

Chapter Seven: Asia-Pacific Nanotechnology Drug Delivery Revenue by Countries

Chapter Eight: South America Nanotechnology Drug Delivery Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Nanotechnology Drug Delivery by Countries

Chapter Ten: Global Nanotechnology Drug Delivery Market Segment by Type

Chapter Eleven: Global Nanotechnology Drug Delivery Market Segment by Application

Chapter Twelve: Global Nanotechnology Drug Delivery Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Nanotechnology Drug Delivery Market Report at: https://www.maximizemarketresearch.com/market-report/global-nanotechnology-drug-delivery-market/39035/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Go here to see the original:

Global Nanotechnology Drug Delivery Market: Industry Analysis and Forecast (2019-2026): By Technology, Application and Region - Publicist360

Charge a Car Battery in 5 Minutes? Thats the Plan – WIRED

Anna Tomaszewska, a chemical engineer at Imperial College London who recently coauthored a review paper on fast-charging lithium-ion batteries, says one possible solution to lithium plating is to add silicon to the anode. Silicon is cheap, abundant, and can change the anodes crystal structure in such a way that makes lithium plating less likely. Silicon has been particularly popular with the manufacturers because it can also improve the energy capacity of the battery, adds Tomaszewska.

Indeed, many companies, including Tesla, have added silicon or silicon oxide to graphite anodes to squeeze some more energy from their lithium-ion cells. But Enevate, an energy storage company based in Southern California, wants to take graphite out of the picture. For the last 15 years, the company has been perfecting an XFC, or extremely fast charging lithium-ion battery with a pure silicon anode.

Earlier this year, the companys researchers announced that their latest generation of batteries could be charged to 75 percent in just five minuteswithout sacrificing energy density. We can have a fast charge without losing out on energy density because were using an inexpensive, pure-silicon approach, says Ben Park, Enevates founder and chief technology officer.

Battery companies are well known for announcing performance breakthroughs in experimental cells that never make it to market. But what sets Enevates technology apart, according to Jarvis Tou, the companys executive vice president, is that its anode material can be readily integrated into existing battery manufacturing processes. Tou says Enevate is already in talks with lithium-ion manufacturers to start integrating Enevates anode into commercial batteries. The first applications for the fast-charge batteries will be for power tools, but that Enevate is working with car manufacturers to include it in EVs as early as 2024.

Other companies are also racing to bring fast-charge anode chemistries to market. StoreDot, an Israeli energy storage company, is developing an EV battery that they expect will charge in under 10 minutes. And last month, researchers from the English battery startup Echion claimed to have built a lithium-ion battery that can charge in just six minutes using an anode made from mixed niobium oxide that is nanoengineered to efficiently transport lithium ions. Weve engineered the material to have a specific crystal structure, says Jean de la Verpillire, the CEO and founder of Echion. You can think of it as these little tunnels at the molecular scale that allow lithium ions to travel very fast into the anode.

These bespoke XFC batteries havent made it out of the lab and into the real world yet. Producing lithium-ion batteries at scale is challenging, and manufacturers have to be persuaded to add new materials into their assembly lines. Thats why companies like Echion and Enevate have prioritized developing anode materials that can be dropped in to existing battery production processes. Both say theyre in talks with battery manufacturers to integrate their anode material in commercial cells. Were not trying to reinvent the wheel, adds de la Verpillire. Going from lab discovery to a product is difficult, but its not black magic.

But building a cheap XFC battery might not require new anode chemistries at all. At NREL, Keyser and his colleagues are focused on optimizing graphite anodes, which are already widely used in EVs. Keyser says the team uses computer models to optimize the routes lithium ions take as they move through an anode and to influence this route by manipulating the size and shape of the graphite particles.

Nanoengineering anode structures is difficult to implement at scale, but Keysers team is also exploring solutions to XFC batteries that dont involve modifying the structure or chemistry of a battery anode at all. For example, intelligent algorithms could be implemented at charging stations to ensure that a battery is never overwhelmed by energy while its charging, which can lead to lithium plating. Tesla does this already, to some extent. Its charging stations and cars communicate so that the charging station delivers the right amount of power for the age and make of the car being recharged.

Visit link:

Charge a Car Battery in 5 Minutes? Thats the Plan - WIRED

Applications of nanotechnology in the automotive industry – Geospatial World

Nanotechnology the creation and use of devices and machines on almost an atomic level is likely to be the driving force behind the next great revolution to benefit humankind. The actual definition of nanotechnology can be quite broad, generally, in scientific and engineering terms, nanotechnology is the manipulation of matter with at least one dimension sized from 1 to 100 nanometers (0.000000001 m). That really does put it on an atomic scale, though the products that can be constructed in this way may be a little larger and can range from microscopic to anything under a millimetre.

While this kind of technology will have applications in many fields, there are likely to be huge advantages in the field of cars and motoring and in the near future, nanotechnology is likely to have a massive impact on the world of driving and vehicles.

It is a fact that nanotechnology can impact so many areas of motoring makes it one of the most important up and coming technologies, and it has attracted the attention of a great number of researchers. This has led to a growing number of breakthroughs in the field, and even more possibilities for this exciting and highly flexible area of science to push different fields of motoring forward. But where is nanotechnology having the greatest influence in car manufacture?

We ask a lot of our internal combustion engines in terms of both increased performance and decreased size and weight. Those two elements together would usually mean disaster for a high-performance engine, but nano-engineering has allowed us to do both, and safely. Engine blocks, which house the fundamental moving parts of the mechanism, were traditionally made of cast iron, because it was the only practical material that could resist the high temperatures and pressures that were produced in the heart of an engine. But engineers soon found that certain grades of aluminium which weighs around a third that of cast iron were found to be suitable too.

But now, engineers have learned how to manipulate aluminiums on an atomic level nanoengineering to create materials that are both stronger while being more lightweight than even the current batch of strong aluminium alloys. This makes them even more fuel efficient while having an increased durability, even in the increasingly hostile conditions found in modern engines. It is a fact that an internal combustion engine performs better and is more efficient at higher temperatures, so this is always a goal for engine designers. We are now also experiencing methods of placing ultra-thin layers of engineering ceramics on metal substrates, creating a surface that is capable of withstanding higher temperatures and wear situations.

Manipulation of either the fundamental structure of the engine block material, or the surface architecture or both, even gives designers far greater scope in heat dissertation, wear characteristics, and strength at elevated temperatures.

We have also seen advances in motor oils, particularly in respect to their ability to withstand the punishing environments of modern engines. Nano-manipulation has created a new breed of oils that are able to cling to internal surfaces for longer, meaning that it is in the right place when the engine starts, so that it offers protection right from the start. Nanotechnology oils are also able to put up with much greater use as the tolerances between engine parts decreases and they operate closer together.

Fuel efficiency, whether the car is petrol, diesel, or electric, is a function of its weight, and even quite small reductions in weight can lead to increase attained mileage significantly. One of the best ways to cut the weight of a vehicle is to use lightweight materials for the structural chassis parts and the exterior, and this is another area where nano-manipulation of materials can create stronger, more lightweight, panels and chassis that are stronger than the ones that they have replaced. Nanotechnology is also responsible for the creation of plastic panels that are able to self-repair and reform themselves following damage.

As the next generation of electric vehicles become common on our streets, engineers and researchers are looking at how to lengthen battery life while increasing performance. This has led to the development of lithium-silicon batteries which promise to boost performance and increase longevity. The latest developments in this fast-moving include silicon nanowires that expand and contract as they absorb and shed lithium ions, and tiny nano-structures with carbon shells protecting lithium-rich silicon cores. This combination allows for more efficient energy transfer, meaning that less energy is lost to the environment as heat and more is supplied to the system.

Nanotechnology is also improving fuel cells the clean alternative technology to hydrocarbon fuels. In these, hydrogen is passed over a catalyst to produce hydrogen ions which then go on to reattached to oxygen and result in energy production. The catalysts are increasingly variations of platinum nano-structures to maximise the surface area and harvest the greatest number of hydrogen ions, thereby maximising energy production too.

Nano-sized layers of inorganic filters are increasingly being applied to the vulnerable surfaces of car bodies, to help protect them from harsh environments, and self-repair to an increasing extent. The smart particles can also help repel dirt and grime, keeping your car looking cleaner, while new developments in orientable surface particles mean that we may soon be able to change the outer colour of our cars by adjusting small electrical charges to them.

Interiors. The use of specialist nanotechnology fabrics is helping to keep the interiors of our cars looking fresh and clean, but also repellent to bacterial affects, creating soft, good looking and completely safe interiors. Once again, developments are being made that will allow the colour of the interior to be changes by reorienting the nano-particles of the material, so that the user can choose any combination of colour that they like, while still having excellent antibacterial properties.

Nanotechnology in cars is becoming big business, and as we find new ways to manipulate materials on an atomic scale, so new applications arise. This will lead to cleaner, quieter, more pleasant cars in the future, and that can only be a good thing.

Note: This is a guest blog by Giles Kirkland, an automotive industry writer and researcher.

See the rest here:

Applications of nanotechnology in the automotive industry - Geospatial World

Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics – Yahoo Finance

VANCOUVER, March 25, 2020 /PRNewswire/ --Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicinesannounced today that the companyentered into a license agreement with FUJIFILM Corporationto adopt PNI's NanoAssemblr technology and complete suite of instruments for Fujifilm'sstate-of-the-art manufacturing facility, compatible with GMP regulations of US, Europe and Japan.

As part of this agreement, Fujifilm has the rights to offer contract manufacturing services using PNI's proprietary technology andalso use PNI technology to develop and commercialize its internal therapeutic drug products. PNI and Fujifilm will work together to combine and democratize the scalable manufacturing of gene therapy and small-molecule based nanomedicines using Fujifilm's and PNI's proprietary technologies.

PNI's NanoAssemblr technology is powered by the disruptive NxGen microfluidics mixing technology designed exclusively for scalable nanomedicine development while maintaining precise control and reproducibility. The NanoAssemblr platform is comprised of the Spark, Ignite, Blaze and GMP Systems that together offer a flexible solution for accelerated, cost-effective development and scalable manufacture of high-quality gene therapy, small molecule and protein-based nanomedicine products.

James Taylor, Co-Founder and CEO of PNI said, "We are thrilled to work with Fujifilm to enable our technology in support of clinical clients as they progress their therapeutic programs from the laboratory to the clinic and commercial. Fujifilm's R&D teams will combinethe PNI platform andtheir proprietary Drug Delivery Systems technologies and we look forward to the seamless scaling up and manufacturing of innovative medicines to impact human well-being."

Nanomedicinesis one of the focus areas of Fujifilm, tapping into itsadvanced technologies such as nano-technology, process engineering technology and analysis technology. "We are excited to work with PNI to bring on board the NanoAssemblr suite of products and cutting-edge nanomedicines manufacturing technology," said Junji Okada, Senior Vice President, General Manager of Pharmaceutical products division, FUJIFILM Corporation. "Tapping into Fujifilm's state of the art technology, expertise and thefacility for the provision of pre-clinical and GMP manufacturing services, we are committed to creating innovative and high-value pharmaceutical productsnot only through internal development but also by providing high quality liposomal formulations to our partner companies."

About Precision NanoSystems Inc.

Precision NanoSystems Inc. (PNI) proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology. For more information, visit http://www.precisionnanosystems.com.

About Fujifilm CorporationFUJIFILM Corporation, Tokyo, Japan is one of the major operating companies of FUJIFILM Holdings Corporation. The company brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2019, the company had global revenues of $22 billion, at an exchange rate of 111 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: http://www.fujifilmholdings.com.

Jane Alleva, Global Marketing Manager, Precision NanoSystems, Phone: 1 888 618 0031, ext 140, mobile 1 778 877 5473

SOURCE Precision Nanosystems

Follow this link:

Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics - Yahoo Finance

Work with 3D printing? Here’s your invitation to help fight Covid-19 – Aircraft Interiors International

Nanofabrica, a manufacturer of 3D printers for precision engineering, is inviting researchers, doctors and manufacturers to apply additive manufacturing techniques to develop medical devices and solutions to help in the fight against Covid-19.

The company is hosting a virtual roundtable on Wednesday, 25 March, at 16:00 GMT+2 and invites all interested parties to join a brainstorming session on how the companys manufacturing capabilities (3D printing with 1 micron resolution over cm sized volume) can be used to develop equipment and supplies needed to fight Covid-19.Possible applications include smart filters for microfluidic chips, anti-bacterial surfaces, complex and precise structures and soft moulds for rapid injection-molding.

Link to event:https://zoom.us/j/324801539

If you are unable to make it for the virtual session, please send an email with all relevant questions and details totovit@nano-fabrica.comand Nanofabricas teamwill reply as soon as possible.

Originally posted here:

Work with 3D printing? Here's your invitation to help fight Covid-19 - Aircraft Interiors International

Virtual Medical Device Meetings You Need to Know About – Medical Device and Diagnostics Industry

3D-printing company hosts virtual roundtable Wednesday

Nanofabrica, a Tel Aviv, Israel-based manufacturer of 3D printers for precision engineering, will host a virtual roundtable for researchers, doctors, and manufacturers to harness the companies manufacturing capabilities to develop medical devices and solutions related to the coronavirus (COVID-19) pandemic. The roundtable is scheduled for 4 p.m. GMT+2 (10 a.m. Eastern Time) Wednesday via Zoom. Professionals unable to join the virtual session are invited to email relevant questions and details to [emailprotected].Click here for the meeting link.

FDA hosts virtual town hall for clinical laboratories

FDA will host a virtual town hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for COVID-19. The event will be from 3 - 4 p.m. Eastern Time.The purpose of this town hall is toanswer technical questions about the development and validation of tests for the virus and FDAs updated policy on COVID-19 diagnostics issued on March 16. The agency alsoplans to hold virtual town halls for clinical laboratories and commercial manufacturers every Wednesday in April from 3 4p.m. Eastern Time.

Call for survey participantsfor online roundtable

LNS Research, a Cambridge, MA-based firm, is asking professionals across industries to take a brief survey about the strategies companies are taking to sustain critical operations during the COVID-19 pandemic. The survey results will be shared during an online roundtable scheduled for 11 a.m. ET. The goal of the event is to enable organizational leaders to share strategies in responding to the crisis, best practices, and how to prepare for the new normal. Register for the event here.

Continue reading here:

Virtual Medical Device Meetings You Need to Know About - Medical Device and Diagnostics Industry

Kanazawa University Research: Insights into the Diagnosis and Treatment of Brain Cancer in Children – PR Newswire UK

KANAZAWA, Japan, March 25, 2020 /PRNewswire/ -- In a recent study published in Autophagy, researchers at Kanazawa University show how abnormalities in a gene called TPR can lead to pediatric brain cancer.

Ependymoma is a rare form of brain cancer that implicates children and is often tricky to diagnose. Since effective treatment options can be initiated only after a well-formed diagnosis, there is a dire need among the medical community to identify markers for ependymoma, which in turn, will help oncologists tailor therapy better. Richard Wong's and Mitsutoshi Nakada's team at Kanazawa University has now shown how one gene closely linked to ependymoma can help with not just diagnosis, but also treatment options for the condition.

A gene known as TPR shows an elevated presence in 38% of ependymoma cases. Thus, the team first sought out to investigate how an increase in the TPR gene correlated to the development of cancer cells. Each gene present in a cell contains a code for the creation of a specific protein. The TPR gene contains the code for an eponymous protein. Therefore, cancer samples from patients were assessed for the levels of TPR protein. As expected, levels of TPR were abnormally high in these tumor tissues.

The researchers then moved on to investigate whether these abnormal TPR levels could lead to cancer progression. For this purpose, mice were implanted with human ependymoma cancer tissue into their brains. The TPR gene was then deleted in these tissues so that the mice were unable to create the TPR protein. When the tumor tissues were subsequently analyzed, a reduction of cancer growth was seen. The TPR gene was thus vital for the growth of ependymoma tumors.

Deletion of the TPR protein is known to induce a process called autophagy within cells. Autophagy is initiated when a cell is under undue stress and results in the death of damaged cells. The patient tumor samples, with their high levels of TPR protein, showed little or no presence of autophagy. However, autophagy was remarkably high in the mice with TPR depletion. Ependymoma cells were thus spared of autophagic death due to the increased presence of TPR. These damaged cells continued to grow by circumventing the biological systems set up to keep them in check. The high TPR levels were also accompanied by an increase in HSF-1 and MTOR, molecules which are responsible for cell growth and survival.

Finally, the possibility of lowering TPR levels therapeutically to control the cancer was assessed. The mice were given a drug called rapamycin, which inhibits MTOR. The treatment not only led to decreased TPR levels, but also shrank the tumor tissues within their brains.

"Thus, TPR can serve as a potential biomarker, and MTOR inhibition could be an effective therapeutic approach for ependymoma patients," conclude the researchers. While looking out for increased levels of TPR in patients can help oncologists achieve a more comprehensive diagnosis, reducing TPR levels with the help of drugs can help keep the tumors in check.

Background:

Autophagy: Autophagy, which literally translates to "self-eating" is the self-preservation mechanism of the body to get rid of damaged cells. Autophagy is initiated when an abnormal amount of proteins or toxins build up within a cell, which the cell cannot clear out. Conditions like Alzheimer's disease and Parkinson's disease arise when autophagic mechanisms within the cells start malfunctioning. Impaired autophagy is also known to be implicated in driving various forms of cancer.

Reference

Firli Rahmah Primula Dewi, Shabierjiang Jiapaer, Akiko Kobayashi, Masaharu Hazawa, Dini Kurnia Ikliptikawati, Hartono, Hemragul Sabit, Mitsutoshi Nakada, and Richard W. Wong. "Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma", Autophagy. Published online 24March2020.

DOI 10.1080/15548627.2020.1741318.

About Nano Life Science Institute (WPI-NanoLSI)

Home

Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology. The objective of this initiative is to form world-tier research centers. NanoLSI combines the foremost knowledge of bio-scanning probe microscopy to establish 'nano-endoscopic techniques' to directly image, analyze, and manipulate biomolecules for insights into mechanisms governing life phenomena such as diseases.

About Kanazawa University

http://www.kanazawa-u.ac.jp/e/

As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949. The University has three colleges and 17 schools offering courses in subjects that include medicine, computer engineering, and humanities.

The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture. The city of Kanazawa has a highly respected intellectual profile since the time of the fiefdom (1598-1867). Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Further information

Hiroe Yoneda Vice Director of Public AffairsWPI Nano Life Science Institute (WPI-NanoLSI)Kanazawa UniversityKakuma-machi, Kanazawa 920-1192, JapanEmail: nanolsi-office@adm.kanazawa-u.ac.jp Tel: +81-(76)-234-4550

SOURCE Kanazawa University

More here:

Kanazawa University Research: Insights into the Diagnosis and Treatment of Brain Cancer in Children - PR Newswire UK

Researchers measure radar cross sections to improve drone detection – Aerospace Testing International

Researchers from Finland, Belgium and the USA have measured the radar cross sections of drones to establish an open-database of known types and improve drone detection methods.

With drones being increasingly used across society and industry for many different applications, they can cause public harm and be used maliciously. The researchers hope the database can be used to help design radar systems and new drone detection techniques to improve public safety.

Radar is commonly used to monitor the presence of drones and prevent possible threats. However, drones are manufactured in a range of sizes, shapes and often use composite materials, making them challenging to detect with radar.

Researchers from Aalto University in Finland, UCLouvain in Belgium, and New York University, USA have gathered extensive radar measurement data of commercially available and custom-built drone models Radar Cross Section (RCS), which indicates how the target reflects radio signals. The RCS signature can help to identify the size, shape and the material of the drone.

Researcher Vasilii Semkin from Aalto University said, We measured drones RCS at multiple 26-40 GHz millimetre-wave frequencies to better understand how drones can be detected and to investigate the difference between drone models and materials in terms of scattering radio signals.

We believe that our results will be a starting point for a future uniform drone database. Therefore, all results are publicly available along with our research paper.

The publicly accessible measurement data could be used in the development of radar systems, as well as machine learning algorithms for more complex identification. This would increase the probability of detecting drones and reducing fault detections.

There is an urgent need to find better ways to monitor drone use. We aim to continue this work and extend the measurement campaign to other frequency bands, as well as for a larger variety of drones and different real-life environments, added Semkin.

Researchers are now studying the possibility that5G base stations could be used in the futurefor surveillance.

We are developing millimetre-wave wireless communication technology, which could also be used in sensing the environment like a radar. With this technology, 5G-base stations could detect drones, among other things, said professorVille Viikarifrom Aalto Universitys Department of Electronics and Nanoengineering.

Read more:

Researchers measure radar cross sections to improve drone detection - Aerospace Testing International

Texas A&M Hagler Institute Inducts 2019-2020 Faculty Fellows, Distinguished Lecturers – Texas A&M University Today

The Hagler Institute for Advanced Study at Texas A&M recently inducted its 2019-20 class of Hagler Fellows. Pictured front row from left: Mario Andrs Hamuy, Deirdre N. McCloskey, Sharon M. Donovan, Edwin L. Ned Thomas, and Peter W. Shor. Back row from left: Kathleen C. Howell, Luiz Davidovich, Misha Lyubich, and Hagler Institute founding director John L. Junkins. Not pictured: Peter J. Hotez and Henry Rousso.

Photo courtesy of Butch Ireland

The Hagler Institute for Advanced Study at Texas A&M University inducted nine Hagler Fellows into the 2019-20 class during its eighth annual gala on Friday, Feb. 28.

The faculty fellows are distinguished in the advancement of research in aeronautics and astronautics, astronomy, history, law, physics, mathematics, materials science and nanoengineering, nutrition and health and tropical medicine. The institute also honored its distinguished lecturers for the 2019-20 academic year.

In remarks to the 200-plus audience in the Bethancourt Grand Ballroom at the Memorial Student Center, Chancellor John Sharp of The Texas A&M University System regarded the Hagler Institute as one of the greatest ways to incorporate distinction and reach Texas A&Ms high standard for academic achievement.

The quality of the professors to come to us through the Hagler Institute for Advanced Study has been nothing short of extraordinary, Sharp said.

Texas A&M President Michael K. Young began by thanking Founding Director John Junkins for his vision and commitment to the institute. Young also thanked Jon Hagler for his generosity and dedication to excellence.

By investing in the excellence of intellectual explorers like the ones we welcome tonight, he has ensured his lasting legacy as a catalyst for groundbreaking scholarship and discovery, Young said.

Keynote speaker Norman Augustine, former chair and CEO of Lockheed Martin and current chair of the Hagler Institutes External Advisory Board, referenced the progress the Hagler Institute has made over the last decade.

Its remarkable growth has been possible by the early support of Chancellor Sharp and the continuing support of President Young as the Hagler Institute now moves into Phase 2.0, Augustine said. Their confidence and the confidence of people like this audience, along with the infinite energy and persistence of John Junkins, have turned a fragile idea into a remarkable institution.

Augustine urged the audience to actively support the work of the Hagler Institute.

Education and research are the engines that drive our economy, and our economy is the engine that, to a considerable extent, drives the quality of our lives, he said.

This years induction of Hagler Fellows includes members of the National Academies of Sciences, Engineering and Medicine, the American Academy of Arts and Sciences and equivalent academies around the world, bringing the total number of past and present Hagler Fellows to 70. Each fellow collaborates with one or more of Texas A&Ms colleges or schools.

The Hagler Institute also formally welcomed its Distinguished Lecturers for 2019-2020.

About the Hagler Institute for Advanced Study: The Hagler Institute for Advanced Study was established in December 2010 by The Texas A&M University System Board of Regents to build on the growing academic reputation of Texas A&M and provide a framework to attract top scholars from throughout the nation and abroad for appointments of up to a year. The selection of Faculty Fellows initiates with faculty nominations of National Academies and Nobel Prize-caliber scholars who align with existing strengths and ambitions of the University. To learn more, visit the Hagler Institute webpage.

See original here:

Texas A&M Hagler Institute Inducts 2019-2020 Faculty Fellows, Distinguished Lecturers - Texas A&M University Today

Smart Materials May Find New Option with Light-Powered Micromotor – ENGINEERING.com

Smart Materials May Find New Option with Light-Powered MicromotorJeffrey Heimgartner posted on March 04, 2020 | Researchers have developed a 5mm micromotor powered by light.

When it comes to converting energy into movement, rotary motors have proven their worth. As new innovations and technology continue to get smaller in size, miniaturizing these kinds of motors has been a focus for researchers at the University of Warsaw. Working with colleagues from the Department of Mathematical Sciences at Xian Jiaotong-Liverpool University in Suzhou, China, the Institute of Applied Physics at Military University of Technology in Warsaw, and the Centre of Polymer and Carbon Materials of Polish Academy of Sciences in Zabrze, Poland, the team developed a micromotor powered by light that could potentially make it easier to miniaturize other components.

Movie of the 5.5 mm diameter micromotor, driven by a rotating laser beam. (Source: UW Physics, Mikoaj Rog)

Despite low speed, around one rotation per minute, our motor allows us to look at the micromechanics of intelligent soft materials from a different perspective and gives food for thought when it comes to their potential use, said Klaudia Dradrach, Photonic Nanostructure Facility.

A 5mm diameter micromotor rotor, made of specially oriented polymer film, fits on a pencil tip. (Image courtesy of the University of Warsaw, Piotr Wasylczyk.)

Since LCEs are considered a smart material, which can be fabricated in a multitude of ways and sizes, the new motor could open doors for new innovations. The new motor, along with the right orientation of the LCEs, could help power and control robotic components with light. It also has the potential to change how wearable smart materials could be made and operate.

With the success of their current micromotor, the researchers are now focusing their efforts on light-controlled microtools and long-range linear actuators.

Interested in more ways tiny innovations are set to make a big difference? Check out Nanoparticles Pave the Way for a Million-Mile EV Battery and Composite Enhancing Nano-Barrier Could Change Spacecraft Construction.

See the original post:

Smart Materials May Find New Option with Light-Powered Micromotor - ENGINEERING.com

Here’s how nanoparticles could help us get closer to a treatment for COVID-19 – News@Northeastern

There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.

Since the outbreak began in late 2019, researchers have been racing to learn more about SARS-CoV-2, which is a strain from a family of viruses known as coronavirus for their crown-like shape.

Northeastern chemical engineer Thomas Webster, who specializes in developing nano-scale medicine and technology to treat diseases, is part of a contingency of scientists that are contributing ideas and technology to the Centers for Disease Control and Prevention to fight the COVID-19 outbreak.

Professor and chair of the Department of Chemical Engineering Tom Webster. Photo by Adam Glanzman/Northeastern University

The idea of using nanoparticles, Webster says, is that the virus behind COVID-19 consists of a structure of a similar scale as his nanoparticles. At that scale, matter is ultra-small, about ten thousand times smaller than the width of a single strand of hair.

Webster is proposing particles of similar sizes that could attach to SARS-CoV-2 viruses, disrupting their structure with a combination of infrared light treatment. That structural change would then halt the ability of the virus to survive and reproduce in the body.

You have to think in this size range, says Webster, Art Zafiropoulo Chair of chemical engineering at Northeastern. In the nanoscale size range, if you want to detect viruses, if you want to deactivate them.

Finding and neutralizing viruses with nanomedicine is at the core of what Webster and other researchers call theranostics, which focuses on combining therapy and diagnosis. Using that approach, his lab has specialized in nanoparticles to fight the microbes that cause influenza and tuberculosis.

Its not just having one approach to detect whether you have a virus and another approach to use it as a therapy, he says, but having the same particle, the same approach, for both your detection and therapy.

SARS-CoV-2 spreads mostly through tiny droplets of viral particlesfrom breathing, talking, sneezing, coughingthat enter the body through the eyes, mouth, or nose. Preliminary research also suggests that those germs may survive for days when they attach themselves to countertops, handrails, and other hard surfaces.

Thats one reason to make theranostics with nanoparticles the focus of the COVID-19 outbreak, Webster says.

Nanoparticles can disable these pathogens even before they break into the body, as they hold on to different objects and surfaces. His lab has developed materials that can be sprayed on objects to form nanoparticles and attack viruses.

Even if it was on a surface, on someones countertop, or an iPhone, he says. It doesnt mean anything because its not the active form of that virus.

That same technology can be fine-tuned and tweaked to target a wide range of viruses, bacteria, and other pathogens. Unlike other novel drugs with large molecular structures, nanoparticles are so small that they can move through our body without disrupting other functions, such as those of the immune system.

Almost like a surveyor, they can go around your bloodstream, Webster says. They can survey your body much easier and under much longer times and try and detect viruses.

To do all that, the CDC needs to know the specifics about what kind of structure is needed to neutralize SARS-CoV-2, Webster says. That information isnt public yet.

You have to identify what we need to put in our nanoparticle to attract it to that virus, he says. The CDC must know that, because theyve developed a kit that can determine if you have [COVID-19], versus influenza, or something else.

An alternative to nanomedicine is producing synthetic molecules. But Webster says that tactic presents some challenges. In the case of chemotherapies used to treat cancer cells, such synthetic drugs can cause severe side effects that kill cancer cells, as well as other cells in the body.

The same thing could be happening with synthetic chemistry to treat a virus, where molecules are killing a lot more than just that virus, Webster says.

Still, Webster acknowledges that there arent many researchers focusing on nanoparticles to kill viruses.

One of the main reasons for the lack of those solutions is that the same benefits that make nanoparticles ideal to fight infectious diseases also make them a concern for the U.S. Federal Drug Administration.

Because of their size, nanoparticles are pervasive (too pervasive, maybe) to seep through other parts of the body. To reduce that risk, Websters lab has focused on using iron oxide. Particles of that make up entail chemistry that is already natural to our bodies and diets.

Even if you have a viral infection, you need more iron, because you could be anemic depending on how bad the infection is, Webster says. Were actually developing these nanoparticles out of chemistries that can help your health.

And, he says, iron-based nanoparticles could be directed with magnetic fields to target specific organs in the body, such as lungs and other areas susceptible to respiratory complications after contracting viral infections. That too, Webster says, is something that you couldnt do with a novel synthetic molecule.

Really, what this all means is that we just have to do the studies to show those iron nanoparticles are not going into the brain or the kidney, Webster says, that these nanoparticles are going exactly where you want them to go to the virus.

For media inquiries, please contact Shannon Nargi at s.nargi@northeastern.edu or 617-373-5718.

See more here:

Here's how nanoparticles could help us get closer to a treatment for COVID-19 - News@Northeastern

UA developing wearable technology to measure sweat ‘biomarkers’ – Tucson Local Media

Researchers at the University of Arizona are developing wearable technology to analyze sweat, which may remove the need to draw blood to learn about the bodys functions in multiple situations.

The project is funded by an 18-month, $519,000 grant from the SEMI Nano-Bio Materials Consortium. The project falls at the crossroads of multiple academic fields, including engineering, chemistry and medicine, and has two main goals: develop a patch to reliably collect the sweat, and develop a biochemistry sensor to analyze the sweat.

When physicians take blood samples, the blood is tested for "biomarkers" which are indicators of medical phenomena like disease or infection. Sweat contains its own index of biomarkers, and collecting it presents a unique series of challenges and advantages.

No matter what molecule you measure in sweat, you need to determine how it relates to the physiological status of the individual, says co-investigator Esther Sternberg, who serves as research director for the Andrew Weil Center for Integrative Medicine and UA professor of medicine. In order to measure the status of the immune system without stressing an individual, one needed to get at immune molecules in a different way than drawing blood, because if you draw blood you need to stick a needle in a person, and thats a stressor If youre trying to understand how the stress response affects the immune response, you need to have a noninvasive, unobtrusive way of measuring the status of the immune response.

Sternberg began working with biomarkers in sweat 20 years ago while working at National Institutes of Health. She says one of the reasons she was drawn to the UA was because of interdisciplinary research projects such as this.

Part of understanding biomarkers in sweat involves using a sweat correlation lab where subjects use exercise bikes to have their sweat collected in a controlled environment.

Were able to relate the levels of the different biomarkers to the exact amount of stress that their bodies are experiencing because we correlate them with heart rate, heart rate variability, breathing and other well-standardized methods to accurately measure the activity of the brain and bodys stress response, Sternberg says. Just measuring the molecules is just the tip of the iceberg, you need to correlate them with all these different measures of the status of the physiological stress response in order to understand what they mean and have actionable results.

One of the first hurdles is how to accurately and quickly collect the sweat. According to project principal investigator Erin Ratcliff, a materials science and engineering professor and head of the UA Laboratory for Interface Science of Printable Electronic Materials, the obvious idea to collect sweat would be to make a patch to gather information from multiple pores at once. However, this means waiting for the space between the patch and skin to fill up with sweat, and during that time, the molecules and biomarkers can chemically change, altering important information.

Ratcliff became involved in this project five years ago, and her role is to convert the biomarkers into an electronic signal that devices use. Current wearable technologies, such as a FitBit, measure bodily data like EKG and heart rate, but dont measure the molecules behind the stress responses, such as cortisol or neuropeptide Y.

Part of the project uses a virtual sweat sensing lab which is a computer simulation that allows researchers to input information about biomarkers, printable materials and device architectures to determine what the output of a sensor would be before they ever make it.

The prototypes that will come out of this 18-month project will be laboratory level with the idea that the components will lead to a product stream for a particular company, but were not going to make thousands of them, Ratcliff says.

While Sternberg says measuring sweat has a tremendous and very wide applicability to many different diseases, it will not completely remove the need to draw blood.

Youre getting information from two different compartments of the body; the blood tells you whats going on in the blood and circulatory system, and sweat tells you whats going on in the tissues and peripheral nervous system I believe this will enhance information and give you information that is not present when you only measure molecules in blood, Sternberg says. Ultimately there may be circumstances in which collecting sweat and collecting molecules from sweat will replace the need to measure the molecules in blood, and in other cases to get a full picture of whats happening in the body, you may need to measure sweat, blood, saliva, urine and on and on.

The U.S. Department of Defense measures "technology readiness" throughout nine levels. According to Ratcliff, the team is aiming for the technology to be at level four at the end of this project. Technology Readiness Level Four means that "basic technological components are integrated to establish that they will work together.

This speaks to the importance of academe and industry working together in an unbiased way, together with federal agencies, to solve complex problems which cant be solved only on the academic side or only on the industry side, Sternberg says. This is an interdisciplinary, multi-college collaboration with an engineer of materials science in Erin Ratcliff, a chemist Ray Runyon, and myself a physician When youre talking about cutting-edge, frontier science, that is the way science has to be done.

Go here to see the original:

UA developing wearable technology to measure sweat 'biomarkers' - Tucson Local Media

Chemistry’s Mahsa Lofti-Marchoobeh Wins Three Minute Thesis Final – University of Arkansas Newswire

Photo submitted by the Office of Graduate Student Support.

Mahsa Lotfi-Marchoobeh delivers her 3MT presentation to the audience.

Mahsa Lotfi-Marchoobeh is the winner of the University of Arkansas Three Minute Thesis competition. She earned the top prize for her presentation A Miniaturized Neural Probe for Detection of Chemicals in the Brain.

As the top finisher, Lotfi-Marchoobeh won $750 and entry to the Conference of Southern Graduate Schools' regional Three Minute Thesis contest.

Lotfi-Marchoobeh is a doctoral student in the Department of Chemistry and Biochemistry and is advised by Ingrid Fritsch. In the regional contest Lotfi-Marchoobeh will compete against roughly 80 students from universities across the Southern Region. The contest will be held March7 in Birmingham, Alabama.

Abass Oduola and Firuze Kordshuli tied for the People's Choice award, voted on by members of the audience. They each won $500 for their presentations. Oduola, a cell and molecular biology doctoral student advised by Griffiths Atungulu, presented Impact of Selected Infrared Wavelengths on Inactivation of Microbes on Rough Rice. Kordshuli presented Incorporation of Cu-SIO2 Nano Particles in PDA/PTFE Thin Films, as part of her doctoral research in mechanical engineering with advisor Min Zou.

Lotfi-Marchoobeh, Oduola and Kordshuli were three of five students who earned a spot in the University of Arkansas final. Each student booked their spot in the final by winning contests in their academic colleges in February.

Follow this link:

Chemistry's Mahsa Lofti-Marchoobeh Wins Three Minute Thesis Final - University of Arkansas Newswire

NASA-funded professor charged with hiding Chinese university ties – The College Fix

Affiliation noted on Chinese university website, research papers, patent applications

A professor kept working for a Chinese university after being hired by the University of Tennessee-Knoxville and failed to disclose the relationship, even after he applied for tenure, according to a federal indictment.

Anming Hu, associate professor in the Department of Mechanical, Aerospace and Biomedical Engineering, was arrested last week andcharged with three counts each of wire fraud and making false statements, the Justice Department said. The university says it has suspended him.

The most serious allegations against Hu stem from his acceptance of funding from NASA while semi-covertly working for Beijing University of Technology, which would violate federal law on NASA funding restrictions. The Knoxville News Sentinel reports:

In 2016, Hu prepared a proposal to work on a NASA-funded project and was informed by a UT employee of the funding restrictions surrounding Chinese companies and universities.

Still, Hu continued to seek and receiveNASA funds for research projects, the indictment states. Later that year, UT submitted aproposal for Hu called, Nanobrazing stainless steel containers for breaking the chain-of-contact (BTC) Mars Sample Return Mission, and in 2018, the university submitted one called,Printed metallic sensors based on 3D printing and laser sintering of nanoinks.

Hu worked on those two projects, for which NASA shelled out $105,000, according to the indictment.

The charges against Hu stem from emails and invoices sent in connection to those projects.

Hu hid his employment with the Beijing university even before UTK hired him in 2013, leaving his position with its Institute of Laser Engineering off his application, according to the indictment. He allegedly checked no on UTK forms that asked him if he worked for any organization or business entity other than UTK.

Yet his name and Beijing university affiliation showed up in multiple public places the university website, at least six published research papers and a dozen patent applications filed in China:

Hu also supervised graduate students in the Institute of Laser Engineering,worked on projectssponsored by the Chinese government and remotely oversawthe operation of a lab in Beijing.

My group there is focusing on super-resolution nano manufacturing and printable electronics, Hu wrote in an email to a U.S. professor in 2017.

The Justice Department said Hu is facing up to 75 years in prison and $750,000 fines if convicted on all counts.

Read the Justice statement and News Sentinel report.

h/t Inside Higher Ed

MORE: Prosecutors call Harvard department chair a secret Chinese agent

IMAGE: AlexLMX/Shutterstock

Read More

Like The College Fix on Facebook / Follow us on Twitter

Visit link:

NASA-funded professor charged with hiding Chinese university ties - The College Fix

Devro lifted by confidence over growth in 2020 – Proactive Investors UK

Devro PLC (LON:DVO) shot up 7% to 157.4p as it said it expects to achieve good progress in 2020 with volume growth in all its markets.

The producer of sausage casings added that cost savings will more than offset cost pressures due to inflation.

In the year to 31 December, it swung to a 21mln loss before tax, from a 17mln profit in 2018, due to closure of a UK facility and non-cash impairment charges related to US and Chinese plants.

TT Electronics plc (LON:TTG) advanced 9% to 208p as the majority of its operations in Asia have restarted after closing to prevent the coronavirus from spreading.

The manufacturer of electronic components has three facilities in China and one in Hong Kong, accounting for 25% of its total revenues.

The company said the closures will hit this years profits by 3mln.

Edenville Energy PLC dipped 2% to 0.044p on Wednesday afternoon as it expects further disruption at its Rukwa mine in Tanzania if the rains continue.

The AIM-listed coal producer said it expects to start mining from the northern area of the project during this month, as the ramp-up in production continues.

The plant is taking material from the 6,000-tonne stockpile established last month which needs to be replenished.

Fellow miner Condor Gold PLC (LON:CNR) was doing much better, rising 9% to 31.75p.

The AIM-listed firm said results from mining dilution studies supporting a 1,000 tonnes per day production feed at the La India project in Nicaragua.

Management said it could be possible by establishing a small plant or a toll milling agreement.

Amigo Holdings PLC (LON:AMGO) jumped 11% to 43.99p inearly afternoon trade as it announced that its founder James Benamor has resigned with immediate effect.

Benamor forced his way back on to the board at the guarantor loans lender in December after resigning post-float in 2018.

Amigo embarked in a transformation programme in August and recently was given some feedback from theFinancial Conduct Authority over areas for improvement, such as increasing the explanation of key information provided to potential guarantors and disclosure on the likelihood that guarantors could be called to make payments.

Meanwhile, Haydale Graphene Industries PLC (LON:HAYD) surged 11% to 1.75p after it said its graphene nano-platelets have been incorporated into a cosmetic face mask recently launched by South Korean firm iCraft.

The masks will utilise the thermal and electrical conductivity of graphene to help the skin absorb its contents.

The AIM-listed firm said thatwhile the initial volume of graphene required to meet early-stage demand may not be significant, the deal marked a significant step-change in the use of the material.

Attraqt Group PLC (LON:ATQT) slid 18% to 32p as its full-year loss before tax widened by 38% to 4mln due to higher staff, research and development costs.

The e-commerce solutions provider said it still expects double-digit growth in its 2020 annual recurring revenue.

Elsewhere, Hostelworld Group PLC (LON:HSW) shed 10% to 94.6p after warning the coronavirus outbreak could hit its quarterly earnings by 4mln.

The budget accommodation provider said trading since late-January had been challenged by the outbreak with a significant impact on global travel demand, particularly within Asia and Europe.

As the coronavirus has spread from region to region, we have observed a material reduction in bookings and an increase in marketing cost as a percentage of net revenue, the company said.

Urban Exposure PLC (LON:UEX) shot up 10% to 64.98p mid-morning after confirming it is in exclusive discussions with Pollen Street Capital following media speculation.

The finance provider to property developers is looking to offload its loan book to Pollen Street, while the existing executive team would buy its asset management business.

If all goes ahead, the firmwill de-list from AIM and return 73p per share to its shareholders.

Meanwhile, Oncimmune Holdings PLC (LON:ONC) jumped 8% to 88p after praising its US partner Biodesix for exceeding expectations.

The two firms have agreed to sell Oncimmunes diagnostic kit EarlyCDT Lung alongside Biodesixs Notify XL2.

They will be offered via a national sales force plugged directly into pulmonologists and, corporately, into national hospital systems.

In the chemicals industry, Itaconix PLC (LON:ITX) advanced 7% to 1.66p on the back of a joint development agreementfor a biodegradable packaging venture.

According to the deal, the unnamed partner will evaluate the use of Itaconix's BIO*Asterix line of functional additives in new biodegradable packaging solutions.

Itaconix said that if the efforts are successful it will produce and supply one or more BIO*Asterix additives for the partner to use in its product range.

Proactis Holdings PLC (LON:PHD) was a bigearly faller on Wednesday, crashing 38% lower to 29p as it revealed it is no longer up for sale.

The business e-commerce solutions provider announced a formal sale process last July but said today that it did not lead to any firm proposals.

The company has now committed to make a series of changes to keep shareholders happy, including the annual re-election of directors.

Similarly, Nanoco Group PLC (LON:NANO) shares tanked 36% to 16p as it said it has not received a formal acquisition offer after months of discussions.

The nano-materials firm, however, said it is still engaging with a number of parties hoping someone will pop the question.

The firm added it continues to review all strategic options including additional funding.

Meanwhile, Intu Properties PLC(LON:INTU) dropped 26% to 7.91p as the shopping centres firm revealed it hasfailed to raise the 1bn-1.5bn lifeline it hadhoped for.

The real estate group said in January that it was in talks with investors, but noted today that many of them were not willing to dish out the money in such an uncertain market.

The firm said other options are being explored, including alternative capital structures and asset disposals, after several expressions of interest.

Sirius Minerals PLC (LON:SXX) is set to be acquired by Anglo American Plc(LON:AAL) for 405mln after its offer was approved at yesterday's shareholder meeting. Over 1,300 investors cast their vote on Tuesday with 80.28% in favour. The offer needed 75% approval to go ahead.

Itaconix PLC (LON:ITX) has inked a joint development agreement for a biodegradable packaging venture. The agreement envisages a collaboration to evaluate the use of Itaconix's BIO*Asterix line of functional additives in new biodegradable packaging solutions.

Haydale Graphene Industries PLCs (LON:HAYD) graphene nano-platelets have been incorporated into a cosmetic face mask recently launched by South Korean firm iCraft. The company said the masks will utilise the thermal and electrical conductivity of graphene to help the skin absorb its contents.

Oncimmune Holdings PLC (LON:ONC) chief executive Adam Hill has heaped praise on the companys American partner following the launch of its lung diagnostic into the worlds largest healthcare market. Biodesix Inc exceeded our expectations, Hill said. Oncimmunes EarlyCDT Lung test will be sold in the US as Notify Lung for use by doctors in identifying nodules at high risk of lung cancer.

SDX Energy PLC (LON:SDX) told investors that the BMK-1 exploration well has encountered commercial quantities of gas in two targeted horizons. BMK-1 was described previously as a play-opening well and the result confirms that the core productive area in Morocco extends north, de-risking some 20bn cubic feet of prospective gas resources. The result is expected to significantly extend the life of resources.

BATM Advanced Communications Ltd (LON:BVC) has seen earnings double in 2019 after what its chief executive said was a great performance in the second half. For the year ended 31 December, the networking tech and bio-medical firm reported earnings (EBITDA) of US$9.8mln, up from US$4.9mln in 2018, while revenues rose to US$123.4mln from US$119.6mln. Adjusted operating profit, meanwhile, was up to US$5.3mln from US$2.6mln.

Allergy Therapeutics PLC (LON:AGY) has made a steady start to the financial year, according to its chief executive Manuel Llobet with revenue and profit up, respectively, by 9% and 10% backed by a strong operational performance. Turnover for the six months to December 31 advanced to 50.5mln from 46.7mln as the firm reported good growth across the product portfolio and a small gain in European market share.

Xpediator PLC (LON:XPD) has taken out a 20-year lease on a new 200,000 sq ft distribution centre at Southampton's container port. The opening of this new facility will take the freight companys UK warehousing capability to approximately 700,000 sq ft with the new distribution centre scheduled to be built in 2021.

Argo Blockchain PLC (LON:ARB) has reported a 56% increase in monthly income from its Bitcoin mining operation while also completing a capacity expansion ahead of schedule. In a monthly update, the cryptomining firm said it had mined around 337.5 Bitcoin equivalent in February, a 37% increase on Januarys figure, generating revenues of 2.54mln compared to 1.63mln in the prior month.

Tekcapital PLC (LON:TEK) revealed that its portfolio company, Salarius Ltd. has signed an agreement with iLevel Brands Inc as part of the launch of North American sales of its new SaltMe! full flavour-low sodium snack line. The UK intellectual property investment group which is focused on creating marketplace value from investing in university technology - said the agreement, combined with a previously announced distribution agreement, will expand Salarius' market penetration and brand awareness for its new potato chip snack line with retail brand placements across the entire East Coast, Midwest and Southwest geographic areas of the United States.

Seeing Machines Limited (LON:SEE) has appointed Stifel Nicolaus Europe Limited as its joint broker with immediate effect to assist in broadening the groups investor base across North America. The advanced computer vision technology company, which designs AI-powered operator monitoring systems to improve transport safety, said Stifels appointment follows a successful introduction to US-based investors in New York in January.

Condor Gold PLC (LON:CNR) has published a low-capex, high-grade open pit mining scenario based on updated mining dilution studies for the La India Gold Project, located in Nicaragua. These dilution studies have demonstrated that Condor Gold could use a selective mining approach to focus on mining lower-volumes of high-grade mineralisation, reducing the size of the required plant and as a result reducing the amount of capex required to build the plant. Alternatively, the focus on high-grade mineralisation could support a toll treatment operation with a nearby plant owned by another operator.

PCF Group Plc (LON:PCF), the AIM-listed specialist bank, has advised that given the current concerns surrounding travel the bank will be offering shareholders the option of viewing the its forthcoming AGM remotely via an online video stream. The group said this does not affect any of the other arrangements for the AGM, which will take place as previously announced at 1 Cornhill, London EC3V 3ND on Friday 6th March 2020 at 10.00am, and to which shareholders remain welcome to attend in person.

Ergomed PLC (LON:ERGO), a company focused on providing specialised services to the pharmaceutical industry, will announce its preliminary results for the year ending 31 December 2019 on 25 March 2020. The group added that Miroslav Reljanovi, its executive chairman, Richard Barfield, chief financial officer and Lewis Cameron, chief operating officer will host a presentation and conference call for analysts at 9.30am GMT on the day of the results at the offices of Numis, 10 Paternoster Square, London EC4M 7LT.

Original post:

Devro lifted by confidence over growth in 2020 - Proactive Investors UK

New Method Helps Observe the Dynamic Motion of Atoms in 2D Materials – AZoNano

Written by AZoNanoFeb 12 2020

Materials science researchers from McCormick School of Engineering of Northwestern University have developed atechnique to observe the atoms dynamic movement in atomically thin two-dimensional (2D) materials.

The new imaging method, which demonstrates the fundamental cause responsible for the performance failure of an extensively-used 2D material, can help scientists to create more reliable and stable materials for upcoming flexible electronic devices and wearables.

These 2D materialsnamely borophene and grapheneare a group of single-layer, crystalline materials that have great potential as semiconductors in next-generation flexible and ultra-thin electronics.

However, the thin nature of these materials makes them extremely susceptible to external settings, and, as a result, they have struggled to show long-term reliability and stability when used in electronic devices.

Atomically thin 2D materials offer the potential to dramatically scale down electronic devices, making them an attractive option to power future wearable and flexible electronics,

Vinayak Dravid, Abraham Harris Professor, Department of Materials Science and Engineering, McCormick School of Engineering, Northwestern University

The study, titled Direct Visualization of Electric Field-induced Structural Dynamics in Monolayer Transition Metal Dichalcogenides, was published in the ACS Nano journalon February 11th, 2020.

The studys corresponding author is Vinayak Dravid.The research also involved Chris Wolverton, the Jerome B. Cohen Professor of Materials Science and Engineering,

Unfortunately, electronic devices now operate as a kind of black box. Although device metrics can be measured, the motion of single atoms within the materials responsible for these properties is unknown, which greatly limits efforts to improve performance, Dravid stated.

Dravid serves as a director of the Northwestern University Atomic and Nanoscale Characterization (NUANCE) Center. The study provides a means to move beyond that restriction, with a new insight into the structural dynamics involved in 2D materials receiving electrical current.

Based on an earlier study where the scientists utilized a nanoscale imaging method to visualize heat-induced failure in 2D materials, the team employed a high-resolution, atomic-scale imaging technique known as electron microscopy to view the motion of atoms in molybdenum disulfide (MoS2). MoS2 is an extensively researched material that was initially utilized as a dry lubricant in friction materials and greases; this dry lubricant was recently in the limelight for its optical and electronic properties.

Upon applying an electric current to the material, the scientists observed that the highly mobile sulfur atoms in this material always move to empty areas within the crystalline material, a phenomenon which the team called atomic dance.

That movement of the atomscaused the grain boundaries of MoS2 to separate and form narrow channels for the electrical current to pass through. Grain boundaries are natural defects produced in the space, where a pair of crystallites inside the material meet.

As these grain boundaries separate, you are left with only a couple of narrow channels, causing the density of the electrical current through these channels to increase. This leads to higher power densities and higher temperatures in those regions, which ultimately leads to failure in the material.

Akshay Murthy, Study Lead Author and PhD Student, Department of Materials Science and Engineering, Northwestern University

Murthy is part of Dravids team.

Its powerful to be able to see exactly whats happening on this scale, continued Murthy. Using traditional techniques, we could apply an electric field to a sample and see changes in the material, but we couldnt see what was causing those changes. If you dont know the cause, its difficult to eliminate failure mechanisms or prevent the behavior going forward.

With this latest method to analyze 2D materials at the atomic level, the researchers believe that investigators can apply this imaging technique to produce materials that are less likely to fail in electronic devices.

For instance, in memory devices, scientists can visualize how regions where data is stored, emerge upon applying an electric current and adapt how those kinds of materials are developed for more improved performance.

The method may even help to enhance a range of other technologies, such as light-emitting diodes (LEDs) in consumer electronics, transistors in bioelectronics, and photovoltaic cells integrated with solar panels.

We believe the methodology we have developed to monitor how 2D materials behave under these conditions will help researchers overcome ongoing challenges related to device stability. This advance brings us one step closer to moving these technologies from the lab to the marketplace.

Akshay Murthy, Study Lead Author and PhD Student, Department of Materials Science and Engineering, Northwestern University

Source: https://www.mccormick.northwestern.edu/

See the original post here:

New Method Helps Observe the Dynamic Motion of Atoms in 2D Materials - AZoNano

Surgical Instruments Tracking Systems Market Development and New Market Opportunities and Forecasts 2028 – Jewish Life News

Surgical Instruments Tracking Systems Market: Introduction

Surgical instruments tracking systems have been accessible for use in medical field for several years. Today, surgical instruments tracking systems have turned into a need. The previous four to five years have witnessed major changes in tracking systems. Rapid advances in instruments tracking systems technologies such as nano-engineering and opto-electrical engineering have created new avenues in recent years. Need for unobtrusive and automated tracking systems will keep demands lucrative in coming years.

Download Brochure of This Market Report at https://www.tmrresearch.com/sample/sample?flag=B&rep_id=5760

The report by TMR Research takes a closer look at recent trends impacting the revenue potential of various playersand offers insights into imminent investment pockets in key markets.

Surgical Instruments Tracking Systems Market: Key Development

Some of the most prominent competitors operating in the competitive landscape of global surgical instruments tracking systems market include

Most players are embracing a few organic and inorganic and natural systems, for example, new launches and product advancements, mergers and acquisitions, and collaborations alongside expansion on regional and global scale for serving the unmet needs of users.

Request For TOC On this Market Report at https://www.tmrresearch.com/sample/sample?flag=T&rep_id=5760

Surgical Instruments Tracking Systems Market Dynamics

Rising instances of surgical instruments left in the human body after medical procedures and instrument scattering are the main considerations driving the evolution of the surgical instruments tracking systems market. As indicated by the National Center for Biotechnology Information (NCBI), the casualty rate of held surgical articles is around 2.0%. Along these lines, the requirement for cutting edge innovations, for example, 2D scanner tags and RFID to follow the held instruments while the patient is still in the task theater, is rising. This factor is anticipated to push the surgical instruments tracking systems market.

Rising popularity of instruments tracking devices by emergency clinics is another main consideration boosting the market development. Following healthcare gadgets and stock administration during work cycle including medical procedure, post-medical procedure, sanitization, and storage systems are a portion of the serious issues supervised by emergency clinics. Along these lines, they are embracing new technologies to follow these gadgets and systems, which thus is relied upon to stimulate the market.

A portion of the regular instruments that are accidently left in a patients body during medical procedure consists of sponges, blades, needles, electrosurgical adapters, clamps, scalpels, safety pins, scissors, and towels. Among these instruments, towels are probably the most common thing left behind by mistake. Surgical instruments left in patients bodies will in general cut veins and puncture blood vessels that might lead to internal bleeding, creating a pressing need for technologies to track these instruments.

Expanding requirement for stock administration and usage of Unique Device Identification (UDI) guidelines by the FDA are foreseen to drive the market. Innovative headways and initiatives by governments to adopt these gadgets is foreseen to additionally boost the market in the coming years.

Surgical Instruments Tracking Systems Market: Geographical Analysis

In 2018, North America contributed sizable revenue shares in the global surgical instruments tracking systems market. The launch of unique device identification (UDI) framework by the U.S. FDA for accurately identifying proof of medicinal gadgets through their distribution networks is one of the central points credited to this lead. Moreover, the presence of well-established healthcare infrastructure, fast adoption of cutting-edge products, and high per capita healthcare consumption in other developed regions, such as Europe, are foreseen to fuel the global surgical instruments tracking systems market.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Link:

Surgical Instruments Tracking Systems Market Development and New Market Opportunities and Forecasts 2028 - Jewish Life News

Kanazawa University Research: Combined Drug Treatment for Lung Cancer and Secondary Tumors – Yahoo Finance

KANAZAWA, Japan, Feb. 10, 2020 /PRNewswire/ -- Researchers at Kanazawa University report in the Journal of Thoracic Oncology a promising novel approach for a combined treatment of the most common type of lung cancer and associated secondary cancers in the central nervous system. The approach lies in combining two cancer drugs, with one compensating for a resistance side effect of the other.

In 20 40% of patients with cancer, metastasis (the development of secondary tumors) in the central nervous system (CNS) occurs. CNS metastatis impacts negatively on a patient's quality of life, and is associated with a poor health prognosis. In a form of cancer known as ALK-rearranged non-small-cell lung cancer (NSCLC), CNS metastatis is known to persist when drugs targeting primary tumors are used.Now, Seiji Yano from Kanazawa University and colleagues have investigated the origins for the resistence to such drugs, and tested a new therapeutic strategy on a mouse model.

The researchers looked at the drug alectinib.Although used in standard treatments for advanced ALK-rearranged NSCLC, approximately 20 30% of patients treated with alectinib develop CNS metastatis, which is attributed to acquired resistance to the drug.

By treating mice first injected with tumor cells with alectinib daily for 16 weeks, the scientists obtained a mouse model displaying alectinib resistance.By biochemical analyses of the mouse brains, Yano and colleagues were able to link the resistance to the activation of a protein known as epidermal growth factor receptor (EGFR).This activation is, in turn, a result of an increase in production of amphiregulin (AREG), a protein that binds to EGFR and in doing so 'activates' it.

Based on this insight, the researchers tested the effect of administering drugs used for inhibiting the action of EGFR in combination with alectinib treatment.The experiments showed that a combination treatment of alctinib with either erlotinib or osimertinib two existing EGFR-inibiting drugs prevented the progression of CNS metastasis, controlling the condition for over 30 days.

The scientists conclude that the combined use of alectinib and EGFR-inhibitors could overcome alectinib resistance in the mouse model of leptomeningeal carcinomatosis (LMC), a particular type of CNS metastasis.Quoting Yano and colleagues: "Our findings may provide rationale for clinical trials to investigate the effects of novel therapies dual-targeting ALK and EGFR in ALK-rearranged NSCLC with alectinib-resistant LMC."

Background

Non-small-cell lung cancer

Non-small-cell lung carcinoma (NSCLC) and small-cell lung carcinoma (SCLC) are the two types of lung cancer. 85% of all lung cancers are of the NSCLC type. NSCLCs are less sensitive to chemotherapy than SCLCs, making drug treatment of the highest importance.

Alectinib is a drug used for treating NSCLC, with good efficiency. However, 20-30% of patients taking the drug develop secondary cancer in the central nervous system (CNS), which is associated with an acquired resistance to alectinib.Seiji Yano from Kanazawa University and colleagues have now made progress towards a novel therapy against this resistance: a combination of alectinib with other drugs.

Epidermal growth factor receptor inhibitors

The drugs that Yano and colleagues tested in combination with alectinib on a mouse model were of a type known as epidermal growth factor receptor (EGFR) inhibitors, including osimertinib and erlotinib. Both are being used as medication for treating NSCLC.The former was approved in 2017 as cancer treatment by the U.S. Food and Drug Administration and the European Commission.Yano and colleagues obtained results showing that EGFR inhibitors counteract resistance to alectinib and have therefore potential in novel therapies for NSCLC and secondary cancers in the CNS.

Reference

Sachiko Arai, Shinji Takeuchi, Koji Fukuda, Hirokazu Taniguchi, Akihiro Nishiyama, Azusa Tanimoto, Miyako Satouchi, Kaname Yamashita, Koshiro Ohtsubo, Shigeki Nanjo, Toru Kumagai, Ryohei Katayama, Makoto Nishio, Mei-mei Zheng, Yi-Long Wu, Hiroshi Nishihara, Takushi Yamamoto, Mitsutoshi Nakada, and Seiji Yano. Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer, Journal of Thoracic Oncology, published online on January 21, 2020.

Story continues

DOI: 10.1016/j.jtho.2020.01.001

URL: https://www.sciencedirect.com/science/article/pii/S1556086420300228

About Nano Life Science Institute (WPI-NanoLSI)

Home

Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology. The objective of this initiative is to form world-tier research centers. NanoLSI combines the foremost knowledge of bio-scanning probe microscopy to establish 'nano-endoscopic techniques' to directly image, analyze, and manipulate biomolecules for insights into mechanisms governing life phenomena such as diseases.

About Kanazawa University

http://www.kanazawa-u.ac.jp/e/

As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949. The University has three colleges and 17 schools offering courses in subjects that include medicine, computer engineering, and humanities.

The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture. The city of Kanazawa has a highly respected intellectual profile since the time of the fiefdom (1598-1867). Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Further information

Hiroe Yoneda Vice Director of Public Affairs WPI Nano Life Science Institute (WPI-NanoLSI) Kanazawa University Kakuma-machi, Kanazawa 920-1192, Japan Email: nanolsi-office@adm.kanazawa-u.ac.jpTel: +81-(76)-234-4550

View original content:http://www.prnewswire.com/news-releases/kanazawa-university-research-combined-drug-treatment-for-lung-cancer-and-secondary-tumors-301001822.html

SOURCE Kanazawa University

Originally posted here:

Kanazawa University Research: Combined Drug Treatment for Lung Cancer and Secondary Tumors - Yahoo Finance



...89101112...203040...